1 Table of Contents: “...5.5.1 Capacity Building in the Department of Patents, Designs and Trademarks, and Intellectual...”

2 Subjects: “...Intellectual Property Management...”

3 Subjects: “...intellectual disability (ID)...”

4 Table of Contents: “...Preface -- Law, Regulation and Guidance -- Pharmaceutical Intellectual Property Rights in China...”

5 Table of Contents: “... on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property...”

6 Table of Contents: “.... Intellectual property -- Bibliography -- Index...”

7 Table of Contents: “...Section I: Biosimilars, Regulatory landscape, health economics and Intellectual Property landscape...”

8 Table of Contents: “... -- Chapter 10. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing...”

9 Table of Contents: “... of Biological Products -- Clinical Trial Design -- Overview of Clinical Trials -- Intellectual Property...”

10 “... this huge challenge. Without the technological, industrial, intellectual, organisational and research...”

11 Table of Contents: “... delivery in anti-aging medicine -- Intellectual property and regulatory issues in drug delivery research...”

12 “..., and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties...”

13 “... and library design, high through-put screening, coding strategies vs. deconvolutions, intellectual property...”

14 Table of Contents: “... And Regenerative Medicines: An Interdisciplinary Understanding -- 28.Ipr: An Overview -- 29.Intellectual Property...”

15 “... analytical methods and also an intellectual leap of faith to accept that drug action is in some way dependent...”

16 “... preclinically the toxicity associated with these new potential drugs, and intellectual property considerations...”

17 “..., pharmacogivilane, scientific investigation and validation, intellectual property rights, and biopiracy are some key...”

18 Table of Contents: “...Contents of the chapter: Patent processes for natural products are problematic, as the intellectual...”

19 “... of the target cells would be ideal as well as intellectually satisfying, most are reluctantly obliged to concede...”